|
US4112111A
(en)
*
|
1975-02-26 |
1978-09-05 |
Sandoz Ltd. |
Indolinylguanidines
|
|
IT1113879B
(it)
*
|
1979-03-15 |
1986-01-27 |
Farmatis Spa |
Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
|
|
LU82949A1
(fr)
*
|
1980-11-20 |
1981-06-04 |
Usv Pharma Corp |
Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
|
|
EP0054892B1
(en)
*
|
1980-12-22 |
1985-09-18 |
SCIENCE UNION ET Cie |
Synthesis of indolines
|
|
JPS57206657A
(en)
*
|
1981-06-16 |
1982-12-18 |
Mitsui Toatsu Chem Inc |
Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
|
|
FR2529785A1
(fr)
*
|
1982-07-09 |
1984-01-13 |
Adir |
Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
|
|
FR2663325B1
(fr)
*
|
1990-06-14 |
1992-09-04 |
Adir |
Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
|
|
FR2663324B1
(fr)
*
|
1990-06-14 |
1992-09-04 |
Adir |
Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
|
|
FR2677886B1
(fr)
*
|
1991-06-18 |
1995-03-31 |
Adir |
Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
|
|
US5319096A
(en)
*
|
1992-04-03 |
1994-06-07 |
Hoechst-Roussel Pharmaceuticals Inc. |
(1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
|
|
IT1288123B1
(it)
*
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
|
KR100668539B1
(ko)
|
2002-08-19 |
2007-01-16 |
화이자 프로덕츠 인크. |
과증식성 질환에 대한 조합요법
|
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
|
JP2008520578A
(ja)
*
|
2004-11-15 |
2008-06-19 |
ニトロメッド インコーポレーティッド |
複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
EP2094643B1
(en)
|
2006-12-01 |
2012-02-29 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
FR2924713B1
(fr)
*
|
2007-12-11 |
2010-01-29 |
Servier Lab |
Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
EP2575808A1
(en)
|
2010-05-28 |
2013-04-10 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
|
MX2015014666A
(es)
|
2013-04-17 |
2016-03-01 |
Pfizer |
Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
EP3911648B1
(en)
|
2019-01-18 |
2024-10-23 |
Astrazeneca AB |
6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof
|
|
TW202314018A
(zh)
*
|
2021-06-21 |
2023-04-01 |
荷蘭商Ａｓｍ Ｉｐ私人控股有限公司 |
用於形成包含氧化銦鎵鋅的層之反應器系統及方法
|
|
WO2023001880A1
(en)
|
2021-07-22 |
2023-01-26 |
Krka, D. D., Novo Mesto |
Bilayer tablet comprising telmisartan and indapamide
|
|
EP4295839A1
(en)
|
2022-06-20 |
2023-12-27 |
KRKA, d.d., Novo mesto |
Combination of valsartan and indapamide
|
|
EP4374855A1
(en)
|
2022-11-22 |
2024-05-29 |
KRKA, D.D., Novo Mesto |
Pharmaceutical dosage form of candesartan and indapamide
|
|
EP4559899A1
(en)
|
2023-11-21 |
2025-05-28 |
KRKA, d.d., Novo mesto |
Synthesis of 1-amino-2-methyl-2,3-dihydroindole by nitrosating 2-methyl-2,3-dihydro-1h-indole and then reducing the obtained 1-nitroso-2-methyl-2,3-dihydroindole with thiourea dioxide
|